Lucas Werner
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Non-parametric differential methylation analysis characterizes histotype-specific promoter regions in epithelial ovarian cancer.
Journal: Epigenetics
Published: September 02, 2026
The phosphoproteome of ovarian carcinoma delineates signaling signatures and potentially druggable targets across histotype stages.
Journal: NPJ precision oncology
Published: January 15, 2026
Proteomic analysis of ovarian carcinoma reveals diagnostic and prognostic biomarkers with histotype- and stage-specificity.
Journal: Journal of ovarian research
Published: September 08, 2025
LMTK3 as a spatially regulated and stage-dependent biomarker in epithelial ovarian tumorigenesis.
Journal: Molecular therapy. Oncology
Published: August 27, 2025
Proteomics discovery of MTDH and SND1 interaction vulnerabilities in ovarian cancer.
Journal: Scientific reports
Published: July 04, 2025
Unveiling histotype-specific biomarkers in ovarian carcinoma using proteomics.
Journal: Molecular therapy. Oncology
Published: May 13, 2025
Integrative analysis of epigenetic and transcriptional interrelations identifies histotype-specific biomarkers in early-stage ovarian carcinoma.
Journal: Journal of ovarian research
Published: March 03, 2025
Novel gene rearrangement leads to altered expression of Hornerin in sensitive and chemoresistant ovarian cancer.
Journal: Translational oncology
Published: February 05, 2025
Showing 1-9 of 9
Last Updated: 09/26/2026